Upgrade to SI Premium - Free Trial

IN8bio, Inc. (INAB) Misses Q4 EPS by 1c

March 13, 2025 4:16 PM

IN8bio, Inc. (NASDAQ: INAB) reported Q4 EPS of ($0.08), $0.01 worse than the analyst estimate of ($0.07).

For earnings history and earnings-related data on IN8bio, Inc. (INAB) click here.

Categories

Earnings